Skip to main content
Milton Boniuk, MD, Ophthalmology, Houston, TX

MiltonBoniukMD

Ophthalmology Houston, TX

Oculo-Plastic & Orbital Reconstructive Surgery, Retinal Disease, Ocular Oncology

Professor, Ophthalmology, Baylor College of Medicine

Dr. Boniuk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Boniuk's full profile

Already have an account?

  • Office

    6550 Fannin St
    Houston, TX 77030
    Phone+1 713-798-6100
    Fax+1 713-798-4231

Education & Training

  • Armed Forces Institute of Pathology
    Armed Forces Institute of PathologyResidency, Ophthalmology, 1959 - 1961
  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1957 - 1959
  • Dalhousie University Faculty of Medicine
    Dalhousie University Faculty of MedicineClass of 1956

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1963 - 2021
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com
  • Fellow (FACS) American College of Surgeons
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • 28th Annual Cullen Course: Clinical Advances in Ophthalmology for Practicing Ophthalmologists 
    Baylor College of Medicine, Houston, Texas - 2/22/2013

Press Mentions

  • NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New Equity for the Company
    NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New Equity for the CompanyFebruary 13th, 2017

Professional Memberships